(Q45830788)

16 December 2017

meta-analysis

0 references

title

Role of aspirin in chemoprevention of esophageal adenocarcinoma: a meta-analysis (English)

1 reference

16 December 2017

0 references

1 reference

1 reference

Nishanth Sivarasan

1

1 reference

16 December 2017

Geoff Smith

series ordinal

2

1 reference

16 December 2017

publication date

1 May 2013

1 reference

16 December 2017

Journal of Digestive Diseases

published in

1 reference

16 December 2017

volume

14

1 reference

16 December 2017

issue

5

1 reference

16 December 2017

page(s)

222-230

1 reference

16 December 2017

Esophageal adenocarcinoma incidence: are we reaching the peak?

cites work

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12047

Quantitative, tissue-specific analysis of cyclooxygenase gene expression in the pathogenesis of Barrett's adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12047

Effect of aspirin and NSAIDs on risk and survival from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12047

The effect of aspirin in the recurrence of colorectal adenomas: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12047

Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12047

Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12047

Epidemiology of adenocarcinoma of the esophagus, gastric cardia, and upper gastric third

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12047

Nonsteroidal anti-inflammatory drugs and esophageal inflammation - Barrett's esophagus - adenocarcinoma sequence: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12047

Nonsteroidal anti-inflammatory drug use associated with reduced incidence of adenocarcinomas of the esophagus and gastric cardia that overexpress cyclin D1: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12047

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12047

Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12047

Environmental risk factors in the development of adenocarcinoma of the oesophagus or gastric cardia: a cross-sectional study in a Dutch cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12047

Aspirin, nonsteroidal anti-inflammatory drugs, and the risks of cancers of the esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12047

Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12047

Regular aspirin use and esophageal cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12047

Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric adenocarcinomas in Los Angeles County.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12047

Use of anti-inflammatory drugs and lower esophageal sphincter-relaxing drugs and risk of esophageal and gastric cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12047

Non-steroidal anti-inflammatory drugs, lower oesophageal sphincter-relaxing drugs and oesophageal cancer. A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12047

Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12047

Incidence of adenocarcinoma among patients with Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12047

Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12047

Patient preferences for the chemoprevention of esophageal adenocarcinoma in Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12047

21 January 2018

Identifiers

DOI

10.1111/1751-2980.12047

1 reference

16 December 2017

PubMed ID

23421723

1 reference

16 December 2017